Skip to main content
Clinical Trials/CTRI/2024/04/066000
CTRI/2024/04/066000
Recruiting
Phase 4

Efficacy and safety of monophasic versus biphasic hyaluronic acid dermal fillers in correction of moderate-to-severe nasolabial folds: A randomized, controlled, double blinded and intraindividual study - NI

Punjab government dental college and hospital Amritsar0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: L00-L99- Diseases of the skin and subcutaneous tissue
Sponsor
Punjab government dental college and hospital Amritsar
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Punjab government dental college and hospital Amritsar

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 25 years or older, with moderate\-to\-severe
  • symmetrical NLFs graded 3 (moderate) or 4 (severe) according to the 5\-
  • grade Nasolabial Fold\- Wrinkle Severity Rating Scale (NLF\-WSRS).
  • Patients with healthy facial skin, free of disease or pathology in the area to
  • be treated.
  • Patients willing to abstain from any other facial, surgical or cosmetic
  • procedures in the treatment area for the duration of clinical study.

Exclusion Criteria

  • Patients with active skin disease, tumors, infection or related condition in or
  • near the area to be treated
  • Patients hypersensitive or allergic to hyaluronic acid, lidocaine or any amide
  • type of anesthetic.
  • Patients with corrective procedures performed or planned in nasolabial
  • region, such as silicone implants, permanent or semi\-permanent fillers, laser
  • therapy, dermabrasion, botulinum toxin application, chemical peeling within
  • one year of the study.
  • Patients who are pregnant, lactating or on oral contraceptives.
  • Patients with tendency to hypertrophic scars, keloid formation, pigmentation

Outcomes

Primary Outcomes

Not specified

Similar Trials